Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues
about
Cancer Stem Cell Plasticity Drives Therapeutic ResistanceTherapeutic targeting of replicative immortalityThe endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsOncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor geneTLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.The enigmatic cytokine oncostatin m and roles in diseaseThe Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.JAK1/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer.Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.Adiponectin Induces Oncostatin M Expression in Osteoblasts through the PI3K/Akt Signaling Pathway.Stabilization of Oncostatin-M mRNA by Binding of Nucleolin to a GC-Rich Element in Its 3'UTR.A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.Effects of oncostatin M on cell proliferation and osteogenic differentiation in C3H10T1/2OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
P2860
Q26770274-1B7B89A3-2699-4961-B41A-7DA7650CE9E0Q27027457-AF51DD80-730A-4607-A3D9-DB1E80C064D1Q27348356-AD095C2E-2257-49AD-8F43-D3C0E06AF964Q28396388-648473A0-A76D-4EBA-AD1A-090F500EE920Q33902576-D1291854-31CF-44CE-BF87-C5AF14D0BD06Q35113473-2169B2BF-1C75-41DC-B960-F248453BC710Q36232040-8FE146B0-E02D-4E0B-A4E8-1027395BDB08Q36407003-B20AE408-F639-4878-AEF8-9E20B1720D1DQ37409222-A2F3BB29-61CA-4FFC-BF37-A0278721C4BEQ38203779-CC26C69D-AE91-4BF9-8210-C4BD9C6726D7Q38669181-9A83C751-A9BB-4AB8-A84B-246ACBCBFDF5Q38780033-5990B772-9DF4-45EB-A991-D10BB0832259Q38790057-0500EF95-0BF2-4EA8-99A9-4AA11370960AQ38808327-9BE9FF29-023E-4AAF-877C-F66CCE98C1DCQ38833070-5112DD08-24BC-4AC6-BE7D-7430B32C3DD4Q38866860-B637B157-A085-48F2-BE93-21A365E9DB8EQ41425790-2A939979-9553-4240-B159-9C10577C1032Q42111852-A5668D44-7983-47F0-8AA8-B3E34854E478Q55413893-E3644D74-F5A1-4189-9E51-3AA5B30EDD8A
P2860
Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-6 and oncostatin-M ...... ncy in mouse and human tissues
@en
Interleukin-6 and oncostatin-M ...... cy in mouse and human tissues.
@nl
type
label
Interleukin-6 and oncostatin-M ...... ncy in mouse and human tissues
@en
Interleukin-6 and oncostatin-M ...... cy in mouse and human tissues.
@nl
prefLabel
Interleukin-6 and oncostatin-M ...... ncy in mouse and human tissues
@en
Interleukin-6 and oncostatin-M ...... cy in mouse and human tissues.
@nl
P2093
P2860
P1476
Interleukin-6 and oncostatin-M ...... ncy in mouse and human tissues
@en
P2093
Atsushi Kiba
Daniel A Smith
Owen N Witte
P2860
P304
P356
10.1158/1541-7786.MCR-13-0238
P577
2013-07-18T00:00:00Z